TY - JOUR
T1 - TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery
AU - Das, K.
AU - Omar, M.F.M.
AU - Ong, C.W.
AU - Rashid, S.B.A.
AU - Peh, B.K.
AU - Putti, T.C.
AU - Tan, P.H.
AU - Chia, K.S.
AU - Teh, M.
AU - Shah, N.
AU - Soong, R.
AU - Salto-Tellez, Manuel
PY - 2008/8
Y1 - 2008/8
N2 - Formalin fixed and paraffin embedded tissue (FFPE) collections in pathology departments are the largest resource for retrospective biomedical research studies. Based on the literature analysis of FFPE related research, as well as our own technical validation, we present the Translational Research Arrays (TRARESA), a tissue microarray centred, hospital based, translational research conceptual framework for both validation and/or discovery of novel biomarkers. TRARESA incorporates the analysis of protein, DNA and RNA in the same samples, correlating with clinical and pathological parameters from each case, and allowing (a) the confirmation of new biomarkers, disease hypotheses and drug targets, and (b) the postulation of novel hypotheses on disease mechanisms and drug targets based on known biomarkers. While presenting TRARESA, we illustrate the use of such a comprehensive approach. The conceptualisation of the role of FFPE-based studies in translational research allows the utilisation of this commodity, and adds to the hypothesis-generating armamentarium of existing high-throughput technologies.
AB - Formalin fixed and paraffin embedded tissue (FFPE) collections in pathology departments are the largest resource for retrospective biomedical research studies. Based on the literature analysis of FFPE related research, as well as our own technical validation, we present the Translational Research Arrays (TRARESA), a tissue microarray centred, hospital based, translational research conceptual framework for both validation and/or discovery of novel biomarkers. TRARESA incorporates the analysis of protein, DNA and RNA in the same samples, correlating with clinical and pathological parameters from each case, and allowing (a) the confirmation of new biomarkers, disease hypotheses and drug targets, and (b) the postulation of novel hypotheses on disease mechanisms and drug targets based on known biomarkers. While presenting TRARESA, we illustrate the use of such a comprehensive approach. The conceptualisation of the role of FFPE-based studies in translational research allows the utilisation of this commodity, and adds to the hypothesis-generating armamentarium of existing high-throughput technologies.
U2 - 10.1080/00313020802198101
DO - 10.1080/00313020802198101
M3 - Article
SN - 1465-3931
VL - 40
SP - 441
EP - 449
JO - Pathology
JF - Pathology
IS - 5
ER -